SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-15-013818
Filing Date
2015-03-04
Accepted
2015-03-04 11:12:49
Documents
1
Group Members
DOMINIQUE SABASSIERNPE COINVEST 1

Document Format Files

Seq Description Document Type Size
1 SC 13G v403360_sc13g.htm SC 13G 79771
  Complete submission text file 0001144204-15-013818.txt   81379
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88748 | Film No.: 15672195
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110
Business Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110 617-345-3000
NATIXIS PRIVATE EQUITY (Filed by) CIK: 0001620390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G